Mingzhao Xing

  • Mingzhao Xing, M.D., Ph.D., is Professor of Medicine, Oncology, Pathology, and Cellular & Molecular Medicine, Director of the Thyroid Tumor Center, and Chief of the Laboratory for Cellular and Molecular Thyroid Research at Johns Hopkins. He is an American board-certified endocrinologist and studies molecular mechanisms of thyroid cancer and clinical translation. He has 150 publications and holds six USA patents related to the discovery and characterization of BRAF V600E and TERT promoter mutations in thyroid cancer and targeting BRAF/MEK to restore thyroid gene expression and radioiodine uptake for thyroid cancer treatment. His work received 11,000 citations, the 2006 Maryland Innovator Award, the 2013 British Endocrine Society’s Endocrine-Related Cancer Research Award, the 2014 Chinese Endocrine Society’s Zhu Xianyi (???) Award, and the 2016 ATA’s Paul Starr Award. He is Associate Editor of Thyroid, Research Committee Chair, and Co-Chair of the 2016-2017 Annual Meeting Program Committee of ATA.



Leave a Reply

  • Upcoming Events


    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts


  • WCTC3.5 Steering Committee:


    Rocco Bellantone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD